Decheng Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Mirviemirvie.cominJul 2025 · $60M
Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical.
BiotechFemTechHealthtechSouth San Francisco, US
Maneesh Jain(Founder)inStephen Quake(Founder)
BoardLisa Iverson(Director)Ursheet Parikh(Director)inMin Cui(Director)inSamir Kaul(Director)in
Co-investorsCorrelation VenturesGaingelsGeneral CatalystGV (Google Ventures)Mayfield FundPortfolia+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





__Twitter.png)
.png)
